Chemotherapeutic copolymers prepared: Via the RAFT polymerization of prodrug monomers

H. N. Son, S. Srinivasan, J. Y. Yhee, D. Das, B. K. Daugherty, G. Y. Berguig, V. G. Oehle, S. H. Kim, K. Kim, Ick Chan Kwon, P. S. Stayton, A. J. Convertine

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Reversible addition-fragmentation chain transfer (RAFT) polymerization was employed to prepare prodrug polymer carrier systems with the chemotherapeutic agent camptothecin (Cam) and the kinase inhibitor dasatinib (Dt). Copolymers were prepared as dense polyethylene glycol brushes via direct copolymerization of the prodrug macromonomers with polyethylene glycol methacrylate (O950, FW ∼ 950 daltons). The brushes display controlled drug release profiles with little burst or late-phase release aberrations. Hydrolysis studies of the hydrophilic copolymers conducted in human serum showed 33 ± 1.7 and 22 ± 2.4% drug release over the course of 144 h for the ester linked Dt and Cam respectively. Polymer morphology was also shown to play a key role in drug release rates. Copolymers with the drug distributed in the copolymer segment showed faster release rates than diblock copolymers where the hydrophobic drug molecules were localized in discreet hydrophobic blocks. The latter materials were shown to self-assemble into polymeric micelles with the drug block separated from the aqueous phase. Live animal imaging in PC-3 (human prostate cancer cell line) tumor xenographs showed that the fluorescently labeled copolymer brushes were trafficked to the tumor 24 hours post injection. Ex vivo analysis of the harvested tissues showed that polymer accumulated in the tumor with kidney excretion. In vitro cytotoxicity measurements conducted in K562-S and K562-R cells demonstrated ability of the macromolecular conjugates to release active drugs. The direct copolymerization of different drug classes into controlled copolymers via RAFT, together with their favorable release profiles, suggest these carriers merit further study as therapeutic systems.

Original languageEnglish
Pages (from-to)4494-4505
Number of pages12
JournalPolymer Chemistry
Volume7
Issue number27
DOIs
Publication statusPublished - 2016 Jul 21

Fingerprint

Prodrugs
Polymerization
Copolymers
Monomers
Camptothecin
Polymers
Brushes
Pharmaceutical Preparations
Tumors
Copolymerization
Polyethylene glycols
K562 Cells
Micelles
Tumor Cell Line
Neoplasms
Prostatic Neoplasms
Esters
Hydrolysis
Phosphotransferases
Cytotoxicity

ASJC Scopus subject areas

  • Polymers and Plastics
  • Organic Chemistry
  • Biochemistry
  • Biomedical Engineering
  • Bioengineering

Cite this

Son, H. N., Srinivasan, S., Yhee, J. Y., Das, D., Daugherty, B. K., Berguig, G. Y., ... Convertine, A. J. (2016). Chemotherapeutic copolymers prepared: Via the RAFT polymerization of prodrug monomers. Polymer Chemistry, 7(27), 4494-4505. https://doi.org/10.1039/c6py00756b

Chemotherapeutic copolymers prepared : Via the RAFT polymerization of prodrug monomers. / Son, H. N.; Srinivasan, S.; Yhee, J. Y.; Das, D.; Daugherty, B. K.; Berguig, G. Y.; Oehle, V. G.; Kim, S. H.; Kim, K.; Kwon, Ick Chan; Stayton, P. S.; Convertine, A. J.

In: Polymer Chemistry, Vol. 7, No. 27, 21.07.2016, p. 4494-4505.

Research output: Contribution to journalArticle

Son, HN, Srinivasan, S, Yhee, JY, Das, D, Daugherty, BK, Berguig, GY, Oehle, VG, Kim, SH, Kim, K, Kwon, IC, Stayton, PS & Convertine, AJ 2016, 'Chemotherapeutic copolymers prepared: Via the RAFT polymerization of prodrug monomers', Polymer Chemistry, vol. 7, no. 27, pp. 4494-4505. https://doi.org/10.1039/c6py00756b
Son HN, Srinivasan S, Yhee JY, Das D, Daugherty BK, Berguig GY et al. Chemotherapeutic copolymers prepared: Via the RAFT polymerization of prodrug monomers. Polymer Chemistry. 2016 Jul 21;7(27):4494-4505. https://doi.org/10.1039/c6py00756b
Son, H. N. ; Srinivasan, S. ; Yhee, J. Y. ; Das, D. ; Daugherty, B. K. ; Berguig, G. Y. ; Oehle, V. G. ; Kim, S. H. ; Kim, K. ; Kwon, Ick Chan ; Stayton, P. S. ; Convertine, A. J. / Chemotherapeutic copolymers prepared : Via the RAFT polymerization of prodrug monomers. In: Polymer Chemistry. 2016 ; Vol. 7, No. 27. pp. 4494-4505.
@article{e3b00dc878344a989ec4e1d363101549,
title = "Chemotherapeutic copolymers prepared: Via the RAFT polymerization of prodrug monomers",
abstract = "Reversible addition-fragmentation chain transfer (RAFT) polymerization was employed to prepare prodrug polymer carrier systems with the chemotherapeutic agent camptothecin (Cam) and the kinase inhibitor dasatinib (Dt). Copolymers were prepared as dense polyethylene glycol brushes via direct copolymerization of the prodrug macromonomers with polyethylene glycol methacrylate (O950, FW ∼ 950 daltons). The brushes display controlled drug release profiles with little burst or late-phase release aberrations. Hydrolysis studies of the hydrophilic copolymers conducted in human serum showed 33 ± 1.7 and 22 ± 2.4{\%} drug release over the course of 144 h for the ester linked Dt and Cam respectively. Polymer morphology was also shown to play a key role in drug release rates. Copolymers with the drug distributed in the copolymer segment showed faster release rates than diblock copolymers where the hydrophobic drug molecules were localized in discreet hydrophobic blocks. The latter materials were shown to self-assemble into polymeric micelles with the drug block separated from the aqueous phase. Live animal imaging in PC-3 (human prostate cancer cell line) tumor xenographs showed that the fluorescently labeled copolymer brushes were trafficked to the tumor 24 hours post injection. Ex vivo analysis of the harvested tissues showed that polymer accumulated in the tumor with kidney excretion. In vitro cytotoxicity measurements conducted in K562-S and K562-R cells demonstrated ability of the macromolecular conjugates to release active drugs. The direct copolymerization of different drug classes into controlled copolymers via RAFT, together with their favorable release profiles, suggest these carriers merit further study as therapeutic systems.",
author = "Son, {H. N.} and S. Srinivasan and Yhee, {J. Y.} and D. Das and Daugherty, {B. K.} and Berguig, {G. Y.} and Oehle, {V. G.} and Kim, {S. H.} and K. Kim and Kwon, {Ick Chan} and Stayton, {P. S.} and Convertine, {A. J.}",
year = "2016",
month = "7",
day = "21",
doi = "10.1039/c6py00756b",
language = "English",
volume = "7",
pages = "4494--4505",
journal = "Polymer Chemistry",
issn = "1759-9954",
publisher = "Royal Society of Chemistry",
number = "27",

}

TY - JOUR

T1 - Chemotherapeutic copolymers prepared

T2 - Via the RAFT polymerization of prodrug monomers

AU - Son, H. N.

AU - Srinivasan, S.

AU - Yhee, J. Y.

AU - Das, D.

AU - Daugherty, B. K.

AU - Berguig, G. Y.

AU - Oehle, V. G.

AU - Kim, S. H.

AU - Kim, K.

AU - Kwon, Ick Chan

AU - Stayton, P. S.

AU - Convertine, A. J.

PY - 2016/7/21

Y1 - 2016/7/21

N2 - Reversible addition-fragmentation chain transfer (RAFT) polymerization was employed to prepare prodrug polymer carrier systems with the chemotherapeutic agent camptothecin (Cam) and the kinase inhibitor dasatinib (Dt). Copolymers were prepared as dense polyethylene glycol brushes via direct copolymerization of the prodrug macromonomers with polyethylene glycol methacrylate (O950, FW ∼ 950 daltons). The brushes display controlled drug release profiles with little burst or late-phase release aberrations. Hydrolysis studies of the hydrophilic copolymers conducted in human serum showed 33 ± 1.7 and 22 ± 2.4% drug release over the course of 144 h for the ester linked Dt and Cam respectively. Polymer morphology was also shown to play a key role in drug release rates. Copolymers with the drug distributed in the copolymer segment showed faster release rates than diblock copolymers where the hydrophobic drug molecules were localized in discreet hydrophobic blocks. The latter materials were shown to self-assemble into polymeric micelles with the drug block separated from the aqueous phase. Live animal imaging in PC-3 (human prostate cancer cell line) tumor xenographs showed that the fluorescently labeled copolymer brushes were trafficked to the tumor 24 hours post injection. Ex vivo analysis of the harvested tissues showed that polymer accumulated in the tumor with kidney excretion. In vitro cytotoxicity measurements conducted in K562-S and K562-R cells demonstrated ability of the macromolecular conjugates to release active drugs. The direct copolymerization of different drug classes into controlled copolymers via RAFT, together with their favorable release profiles, suggest these carriers merit further study as therapeutic systems.

AB - Reversible addition-fragmentation chain transfer (RAFT) polymerization was employed to prepare prodrug polymer carrier systems with the chemotherapeutic agent camptothecin (Cam) and the kinase inhibitor dasatinib (Dt). Copolymers were prepared as dense polyethylene glycol brushes via direct copolymerization of the prodrug macromonomers with polyethylene glycol methacrylate (O950, FW ∼ 950 daltons). The brushes display controlled drug release profiles with little burst or late-phase release aberrations. Hydrolysis studies of the hydrophilic copolymers conducted in human serum showed 33 ± 1.7 and 22 ± 2.4% drug release over the course of 144 h for the ester linked Dt and Cam respectively. Polymer morphology was also shown to play a key role in drug release rates. Copolymers with the drug distributed in the copolymer segment showed faster release rates than diblock copolymers where the hydrophobic drug molecules were localized in discreet hydrophobic blocks. The latter materials were shown to self-assemble into polymeric micelles with the drug block separated from the aqueous phase. Live animal imaging in PC-3 (human prostate cancer cell line) tumor xenographs showed that the fluorescently labeled copolymer brushes were trafficked to the tumor 24 hours post injection. Ex vivo analysis of the harvested tissues showed that polymer accumulated in the tumor with kidney excretion. In vitro cytotoxicity measurements conducted in K562-S and K562-R cells demonstrated ability of the macromolecular conjugates to release active drugs. The direct copolymerization of different drug classes into controlled copolymers via RAFT, together with their favorable release profiles, suggest these carriers merit further study as therapeutic systems.

UR - http://www.scopus.com/inward/record.url?scp=84979036039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979036039&partnerID=8YFLogxK

U2 - 10.1039/c6py00756b

DO - 10.1039/c6py00756b

M3 - Article

AN - SCOPUS:84979036039

VL - 7

SP - 4494

EP - 4505

JO - Polymer Chemistry

JF - Polymer Chemistry

SN - 1759-9954

IS - 27

ER -